Filip Janku insider trades

Open-market stock purchases and sales by Filip Janku, Chief Medical Officer at Monte Rosa Therapeutics, Inc, from SEC Form 4 filings since Jun 23, 2021.

Recent trades

DateStockTradeValue
Jun 29, 2026GLUE Monte Rosa Therapeutics, IncSold$138K
Jun 29, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jun 24, 2026GLUE Monte Rosa Therapeutics, IncSold$643K
Jun 24, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jun 23, 2026GLUE Monte Rosa Therapeutics, IncSold$240K
Jun 23, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Feb 23, 2026GLUE Monte Rosa Therapeutics, IncSold$179K
Jan 5, 2026GLUE Monte Rosa Therapeutics, IncSold$47.9K
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—
Jan 2, 2026GLUE Monte Rosa Therapeutics, IncBought (not open market)—

Companies traded

  • GLUE Monte Rosa Therapeutics, Inc: 5 sales, last Jun 29, 2026

Get free alerts when Filip Janku files a new trade →